Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Diabetic Nephropathy
Interventions
DRUG

Telmisartan, Ramipril

80 mg of telmisartan administered for 8weeks,followed by addition of ramipril 10 mg for further 8weeks

Trial Locations (1)

1600012

Post Graduate Institute of Medical Education and Research, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT00738660 - Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy | Biotech Hunter | Biotech Hunter